Literature DB >> 31680013

US Food and Drug Administration approval of esketamine and brexanolone.

Ioana A Cristea1, Florian Naudet2.   

Abstract

Mesh：

Substances：

Year:  2019        PMID： 31680013     DOI： 10.1016/S2215-0366(19)30292-5

Source DB:  PubMed          Journal:  Lancet Psychiatry        ISSN： 2215-0366            Impact factor:   27.083


× No keyword cloud information.
  14 in total

Review 1.  Mechanisms of ketamine and its metabolites as antidepressants.

Authors:  Evan M Hess; Lace M Riggs; Michael Michaelides; Todd D Gould
Journal:  Biochem Pharmacol       Date:  2021-12-27       Impact factor: 5.858

2.  Effects of Acute Drug Administration on Emotion: A Review of Pharmacological MRI Studies.

Authors:  Kathryne Van Hedger; Leah M Mayo; Anya K Bershad; Racheal Madray; Harriet de Wit
Journal:  Curr Addict Rep       Date:  2021-03-14

Review 3.  Major Depressive Disorder: Advances in Neuroscience Research and Translational Applications.

Authors:  Zezhi Li; Meihua Ruan; Jun Chen; Yiru Fang
Journal:  Neurosci Bull       Date:  2021-02-13       Impact factor: 5.203

Review 4.  Physiological markers of rapid antidepressant effects of allopregnanolone.

Authors:  Peter M Lambert; Xinguo Lu; Charles F Zorumski; Steven Mennerick
Journal:  J Neuroendocrinol       Date:  2021-08-22       Impact factor: 3.627

5.  Esketamine clinical trials: reply to Maju et al.

Authors:  C Gastaldon; D Papola; G Ostuzzi; C Barbui
Journal:  Epidemiol Psychiatr Sci       Date:  2020-04-29       Impact factor: 6.892

6.  How to deprescribe esketamine in resistant depression? A point of view after first clinical uses.

Authors:  T Taillefer de Laportalière; A Yrondi; A Jullien; P Cestac; F Montastruc
Journal:  Epidemiol Psychiatr Sci       Date:  2022-01-11       Impact factor: 6.892

7.  Disrupting the α7nAChR-NR2A protein complex exerts antidepressant-like effects.

Authors:  Anlong Jiang; Ping Su; Shupeng Li; Albert H C Wong; Fang Liu
Journal:  Mol Brain       Date:  2021-07-05       Impact factor: 4.041

Review 8.  Vasopressin V1B Receptor Antagonists as Potential Antidepressants.

Authors:  Shigeyuki Chaki
Journal:  Int J Neuropsychopharmacol       Date:  2021-07-14       Impact factor: 5.176

Review 9.  Allopregnanolone: An overview on its synthesis and effects.

Authors:  Silvia Diviccaro; Lucia Cioffi; Eva Falvo; Silvia Giatti; Roberto Cosimo Melcangi
Journal:  J Neuroendocrinol       Date:  2021-06-29       Impact factor: 3.870

10.  The evidence base for psychotropic drugs approved by the European Medicines Agency: a meta-assessment of all European Public Assessment Reports.

Authors:  Florian Erhel; Alexandre Scanff; Florian Naudet
Journal:  Epidemiol Psychiatr Sci       Date:  2020-04-27       Impact factor: 6.892
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.